Privium Fund Management B.V. - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 3 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Privium Fund Management B.V. ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$81,473
-47.1%
34,967
-48.3%
0.02%
-25.0%
Q2 2023$154,076
+23.9%
67,5770.0%0.03%
-23.8%
Q1 2023$124,342
-39.5%
67,577
-40.5%
0.04%
-46.2%
Q4 2022$205,486
-18.8%
113,5280.0%0.08%
-15.2%
Q3 2022$253,000
-9.3%
113,528
+15.2%
0.09%0.0%
Q2 2022$279,000
+102.2%
98,528
+198.6%
0.09%
+196.8%
Q1 2022$138,00033,0000.03%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q4 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,283,966$15,166,0001.40%
Sio Capital Management, LLC 591,870$3,930,0000.98%
TFG Asset Management GP Ltd 2,500,000$16,600,0000.90%
Ikarian Capital, LLC 1,356,048$9,004,0000.73%
SABBY MANAGEMENT, LLC 400,050$2,656,0000.37%
Nantahala Capital Management 1,793,500$11,909,0000.34%
Regency Capital Management Inc.\DE 57,000$378,0000.29%
Eversept Partners, LP 473,074$3,141,2110.21%
MYDA Advisors LLC 85,000$564,0000.14%
Henry James International Management Inc. 54,047$359,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders